Table 2 Changes in biochemical parameters

From: Significance of estimated salt excretion as a possible predictor of the efficacy of concomitant angiotensin receptor blocker (ARB) and low-dose thiazide in patients with ARB resistance

 

0 M (n=93)

3 M (n=93)

12 M (n=74)

Blood test

 Albumin (g dl−1)

4.33±0.39

4.28±0.31

4.25±0.40

 eGFR (ml min−1)

78.8±19.8

71.8±19.3**

71.3±0.20.2**

 Urea nitrogen (mg dl−1)

15.5±4.3

17.1±5.0**

16.3±4.3

 Uric acid (mg dl−1)

5.73±1.70

5.63±1.62

5.89±1.73

 Na (mEq l−1)

141.2±1.6

140.1±2.1

140.6±2.4

 K (mEq l−1)

4.27±0.57

4.27±0.60

4.16±0.59

 Cl (mEq l−1)

103.7±2.7

101.9±3.1

102.0±2.5

 BNP (pg ml−1)

22.9 (10.9, 37.7)

16.0 (6.7, 33.6)**

14.4 (5.4, 41.0)**

 FBS (mg dl−1)

119.4±51.8

110.7±33.0

117.6±39.0

 A1c (%)

5.4±1.1

5.5±1.0

5.6±1.1

Urine test

 Creatinine (g l−1)

0.84±0.54

0.80±0.22

0.91±0.59

 Na (mEq per g of Cr)

120.8±51.9

130.8±66.5

121.1±57.0

 K (mEq l−1)

35.9±26.9

40.9±30.4

34.4±23.4

 ACR (μg per mg of Cr)

11.2 (5.8, 46.3)

8.7 (4.6, 16.5)**

4.6 (2.8, 14.9)**,##

  1. Abbreviations: ACR, albumin-to-creatinine ratio; BNP, brain natriuretic peptide; eGFR, estimated glomerular filtration rate; FBS, fasting blood sugar; M, months.
  2. Note: Values of BNP and ACR are expressed as the median (1st quartile, 3rd quartile).
  3. *P<0.05 vs. 0 M, **P<0.01 vs. 0 M.
  4. #P<0.05 vs. 3 M, ##P<0.01 vs. 3 M.
Back to article page